Dear AuntMinnieEurope Member,
Regular followers of the Maverinck will know that he often quite enjoys playing the grinch, and that's certainly the case in his December column.
He's concerned about the rapid growth of teleconsultations and ratings websites, particularly their impact on the patient-doctor relationship. His articles are always well researched and timely, and his latest offering is no exception. Learn more in the Artificial Intelligence Community.
The list of semifinal candidates for the 2021 EuroMinnies is available now. This is based on your nominations, and I'd like to thank everyone who took part. You've given our judging panel a very difficult task to decide on the finalists. We'll reveal that lineup later in January.
When it comes to cases of persistent or recurrent primary hyperparathyroidism, adopt a multimodality approach to imaging that includes PET/CT. That's the overriding message of a master class given at RSNA 2020 by researchers at Imperial College Healthcare NHS Trust in London, who received a certificate of merit for their analysis. Don't miss our news report in the Molecular Imaging Community.
It's widely agreed that the COVID-19 pandemic has had a particularly significant impact on the nuclear medicine sector in Europe. But how, exactly? To find out, we conducted interviews with two leading industry executives, and their responses are certainly revealing and full of insight.
Contrast-enhanced spectral mammography (CESM) -- also known as contrast-enhanced dual-energy mammography -- is making sustained progress and gaining clinical acceptance, but some challenges remain, according to Spanish researchers. They shared their experiences of CESM recently at the RSNA 2020 meeting and won a certificate of merit award for their efforts. Find out more in the Women's Imaging Community.
Our editorial team will continue working next week, so please do look out for further updates.
